Option chain shows key data for LeanLife Health's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for LeanLife Health.

LeanLife Health (OTC:LNLHF) Stock, Option Chain

LeanLife Health Inc is engaged in the business of proprietary plant-based food products and an energy drink. The Company focuses on two business objectives, its plant-based food products (flax seed oils) and energy drink line.

LEANLIFE HEALTH INC by Leanlife Health Inc.

LeanLife Health Inc

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) exchange-traded funds (ETFs) have experienced a decline in value following a recent drop in Bitcoin&#8217;s price. This downturn reflects the ongoing volatility in the cryptocurrency market, impacting investors and related financial products.
What Happened: Bitcoin ETFs saw a decline as Bitcoin&#8217;s value decreased. According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, on Wednesday during pre-market hours, the Bitwise Bitcoin ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>) fell by 2.05%, while the iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) decreased by 1.94%.
The Grayscale Bitcoin Trust (BTC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#NYSE">GBTC</a>) experienced a decline of 1.90%, and the ARK 21Shares Bitcoin ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKB#BATS">ARKB</a>) was down by 1.83%.
The drop in these ETFs follows Bitcoin&#8217;s price falling from $106,000.
At the time of reporting, Bitcoin was trading at $104,766.10. This decrease in Bitcoin&#8217;s value has affected the performance of related ETFs, showcasing the volatility commonly associated with cryptocurrency investments.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42514226/shiba-inu-burn-rate-surges-3609-as-dogecoin-whales-move-5-8-billion-doge-what-is-going-on?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Shiba Inu Burn Rate Surges 3,609% As Dogecoin Whales Move 5.8 Billion DOGE: What Is Going On?</a>
Why It Matters: The recent decline in Bitcoin ETFs is part of a <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42545419/bitcoin-ethereum-dogecoin-stay-muted-before-feds-interest-rate-decision-analyst-says-btc-in-parabolic-phase-reveals-its-duration">broader trend of volatility</a> in the cryptocurrency market.
On Tuesday, Bitcoin reached a new all-time high of $108,000 before experiencing a sharp decline to $105,000. This volatility occurred ahead of the Federal Reserve&#8217;s final policy decision of 2024, which kept investors on edge.
Additionally, veteran investor Ross Gerber hinted at a promising future for Bitcoin, <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42547334/the-new-gold-seasoned-investor-ross-gerber-spots-a-pot-of-bitcoin-at-the-end-of-the-rainbow">likening it to gold</a> in a cryptic message shared on social media. Gerber&#8217;s comments suggest that despite current fluctuations, some investors remain optimistic about Bitcoin&#8217;s long-term potential.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/24/12/42519107/if-you-invested-1000-in-bitcoin-when-the-first-bitcoin-etf-was-filed-heres-how-much-youd-have-today?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">If You Invested $1,000 In Bitcoin When The First Bitcoin ETF Was Filed, Here&#8217;s How Much You&#8217;d Have Today</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

ETFs

General

$BTC

ARK 21Shares Bitcoin ETF ARK 21Shares Bitcoin ETF

ARKB

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

GBTC

IBIT

Bitcoin ETFs Decline As King Crypto Falls To $104,000

B of A Securities analyst Justin Post maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Neutral and raises the price target from $154 to $159.

Price Target

Analyst Ratings

ABNB

B of A Securities Maintains Neutral on Airbnb, Raises Price Target to $159

Former BitMEX CEO Arthur Hayes on Wednesday issued a stark warning about a potential "harrowing dump" in cryptocurrency markets around Donald Trump's <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42232116/dogecoin-to-hit-69-cents-by-inauguration-day-polymarket-traders-are-not-convinced">inauguration on Jan. 20, 2025.</a>
What Happened: Hayes argues that overly optimistic investor expectations for Trump's economic policies will clash with the slow pace of real-world change, leading to a sharp sell-off.
In his latest blog post <a href="https://cryptohayes.substack.com/p/trump-truth?utm_campaign=post&amp;utm_medium=web&amp;triedRedirect=true">titled</a> &#8220;Trump Truth&#8221;, Hayes outlines his outlook for the crypto market as Trump prepares to assume office for his second term.
Hayes believes that while Trump's policies are likely to favor asset price inflation and a weaker U.S. dollar in the long term, immediate results are unlikely. 
"The market believes that Trump and his people can immediately achieve economic and political miracles," Hayes wrote. He warns that the crypto market will face a reality check, saying, "I believe the crypto markets will experience a harrowing dump around Trump's January 20th 2025 inauguration day."
Hayes explains that Trump has only one year to implement any significant policy changes before mid-term campaigning begins in late 2025, which will limit his administration's ability to enact meaningful reforms. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42537836/litecoin-hbar-etfs-could-come-before-xrp-solana-heres-why">Litecoin, HBAR ETFs Could Come Before XRP, Solana: Here&#8217;s Why</a>
He added that <a href="https://www.benzinga.com/news/24/12/42257531/heres-how-ray-dalio-thinks-trumps-second-term-could-reshape-the-us-and-the-world">structural economic issues</a> cannot be solved within such a short timeframe, setting up investors for disappointment.
Despite predicting short-term volatility, Hayes remains confident in the broader bull market for cryptocurrencies, particularly Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>). 
He believes Trump's policy goals—including weakening the U.S. dollar to reindustrialize America—will ultimately increase the global supply of fiat currency and drive demand for hard assets like Bitcoin. 
"Trump Truth shows me the structural deficiencies of the global order… The best way to maximize returns is to own Bitcoin and crypto," he emphasized.
While Hayes acknowledges the risks of timing the market, he outlined his firm Maelstrom's strategy of reducing exposure ahead of the inauguration, with plans to buy back positions during the anticipated sell-off. 
"Maelstrom will be lightening up on certain positions in advance, hoping to rebuy some core positions at lower prices sometime in 1H25," he wrote.
What&#8217;s Next: Hayes concluded by cautioning traders against underestimating the challenges Trump will face and stressed that, while a near-term correction is likely, he remains committed to long-term crypto investments.
"We are committed to admitting defeat if the bull market steamrolls through January 20th, licking our wounds, and getting back on the bull."
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42526592/bitcoin-ethereum-etfs-see-688m-net-inflows-analysts-target-124000">Bitcoin, Ethereum ETFs See $688M Net Inflows, Analysts Target $124,000</a></li>
</ul>
Image: Shutterstock

Trump Inauguration Could Coincide With A 'Harrowing Dump' For Crypto, Arthur Hayes Warns

- Approval in Hong Kong marks the first clinical trial application clearance of an in vivo gene editing approach for chronic hepatitis B in Hong Kong and the second CTA approval for PBGENE-HBV in 2024
- ELIMINATE-B is a global, multi-site study now actively recruiting patients; expected to report clinical data as it matures throughout 2025
- U.S. investigational new drug (IND) anticipated in 2025

DTIL

Precision BioSciences Secures Approval In Hong Kong To Expand Global Phase 1 Trial for PBGENE-HBV Gene Editing Therapy

ORGN

Origin Materials Reports Production Of PET Caps With New Features As Commercial Qualification Continues

B of A Securities analyst Justin Post maintains Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) with a Neutral and raises the price target from $4850 to $5522.

BKNG

B of A Securities Maintains Neutral on Booking Holdings, Raises Price Target to $5522

"We are thrilled with the tremendous progress we've made in collaboration with Tesla, having already achieved, as of December 15th, 350,000 paid subscribers", said Robert Ellin, CEO of LiveOne. "This partnership allows us to leverage our entire tech stack, including AI, to deliver highly personalized experiences, further enriching our users' engagement and driving business growth."

LiveOne-Tesla Partnership Hits 350K Paid Subscribers, Highlights $16M Cash Position

B of A Securities analyst Jessica Reif Ehrlich maintains Fox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) with a Buy and raises the price target from $50 to $55.

FOXA

B of A Securities Maintains Buy on Fox, Raises Price Target to $55

ONCY

Oncolytics Biotech Reveals Presentation Of Two Data Sets Through Two Abstracts Showcasing Pelareorep's Potential In Difficult-to-treat Gastrointestinal Cancers At ASCO

B of A Securities analyst Justin Post upgrades Expedia Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>) from Neutral to Buy and raises the price target from $187 to $221.

Upgrades

EXPE

B of A Securities Upgrades Expedia Group to Buy, Raises Price Target to $221

Shareholder Firstlight Management Urges Board Of Sotera Health For Sale Of Nelson Labs Subsidiary

PERI

Perion And Experian Team Up To Boost AI-Powered Ad Solutions Across Devices

PLTR

Pray.com And Palantir Join Forces To Enhance Multilingual Faith-Based Content Using Advanced AI Technology

B of A Securities analyst Tazeen Ahmad initiates coverage on KalVista Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KALV#NASDAQ">KALV</a>) with a Buy rating and announces Price Target of $22.

Initiation

KALV

B of A Securities Initiates Coverage On KalVista Pharma with Buy Rating, Announces Price Target of $22

Rosenblatt analyst Hans Mosesmann maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Buy and maintains $250 price target.

Rosenblatt Maintains Buy on Micron Technology, Maintains $250 Price Target

Beyond the strategic partnership with Sysco, Square also announced new features to help restaurants run their businesses easily and efficiently. These features are currently rolling out to sellers, with full availability in early 2025.

Square Enters New Partnership With Sysco

B of A Securities analyst Saurabh Pant maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Buy and raises the price target from $42 to $48.

B of A Securities Maintains Buy on Baker Hughes, Raises Price Target to $48

Citigroup analyst Paul Lejuez initiates coverage on On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Neutral rating and announces Price Target of $65.

ONON

Citigroup Initiates Coverage On On Holding with Neutral Rating, Announces Price Target of $65

Mizuho analyst John Baumgartner maintains Nomad Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOMD#NYSE">NOMD</a>) with a Outperform and lowers the price target from $28 to $24.

NOMD

Mizuho Maintains Outperform on Nomad Foods, Lowers Price Target to $24

Barry will continue to report to ICON's Chief Executive Officer, Steve Cutler.

Comments

LeanLife Health

LeanLife Health (LNLHF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga